Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...

Coffee has anti-inflammatory anti-fibrotic and antioxidant properties which help in boosting liver health Read this article ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Additional analysis of data from the NAVIGATE trial showed statistically significant 68.1% (p=0.02) reduction in the incidence of new varices ...

Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...

Professor Dr Mohamed Rela, a world-renowned liver transplant surgeon, joins King’s College Hospital Dubai to lead the paediatric liver transplant team, enhancing advanced liver transplant services in ...

Hepatitis C treatment has undergone a remarkable transformation New antiviral medications offer shorter more effective ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...